期刊文献+

腹盆腔晚期肿瘤腹腔热化疗配合同步静脉化疗及中药扶正治疗的临床观察 被引量:1

Clinical observation of intraperitoneal heat chemotherapy combined with concomitant intravenous chemotherapy and Chinese medicine supporting therapy in the treatment of late-stage abdominal and pelvic cancer
在线阅读 下载PDF
导出
摘要 目的探索腹盆腔晚期恶性肿瘤较好的治疗措施。方法1998年5月至2004年5月将救治的71例晚期腹盆腔恶性肿瘤患者随机分为治疗组和对照组。治疗组36例实施腹腔热化疗配合同步静脉化疗及中药扶正治疗;对照组35例采用单一的静脉化疗。观察两组患者的近期疗效、生活质量、体重、生存期的变化及毒副反应。结果治疗组临床收益率(CR+PR)、生活质量、体重、生存率均较对照组高(P<0.05)。毒副反应也较对照组低(P<0.05)。未见相关并发症的发生。结论疗效对比观察结果表明,应用腹腔热化疗配合同步静脉化疗及中药扶正治疗对晚期腹盆腔肿瘤有较好的治疗作用,比单一静脉化疗效果明显。 Objective To seek a good method for treatment of the abdominal and pelvic cancer in late stage. Methods Seventy-one patients with late-stage abdominal/pelvic cancer treated in this department from May, 1998 to May, 2005 were randomly divided into experimental group and control group. Thirty-six patients of the experimental group accepted the combination treatment with intraperitoneal heat chemotherapy together with intravenous chemotherapy and Chinese medicine supporting therapy, while 35 patients in the control group were treated with intravenous chemotherapy alone. Short-term therapeutic efficacy, quality of life,body weight,survival time and toxic side effects between the two groups were compared. Results The clinical benefit index( CR + PR) ,quality of life ,body weight and survival rate in the experimental group were better than those in the control group ( P 〈 0.05 ). There was less toxic and side effects in the experimental group (P 〈 0.05 ) and no related complication was abserved. Conclusions The results indicate that the combination treatment has apparent curative effects on the abdominal and pelvic cancer in late stage and is a method superior to the intravenous chemotherapy alone.
出处 《中国肿瘤临床与康复》 2006年第5期419-421,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 腹腔/盆腔 肿瘤 热灌注化疗 静脉化疗 中药扶正治疗 Abdomina cavity/pelvic cavity Neoplasms Intraperitoneal heat chemotherapy Intravenous chemotherapy Chinese medicine supporting therapy
  • 相关文献

参考文献4

二级参考文献20

  • 1卿三华,周锡庚,周正端,丁长囡,姚明.高剂量大容积5-Fu腹腔化疗药代动力学和疗效实验观察[J].中国肿瘤临床,1996,23(1):2-5. 被引量:60
  • 2Maruyama M, Toukairin Y, Baba H, et al. Pharmacokinetic study of the intraperitoneal administration of CPT-11 for patients with peritoneal seedings of gastric and colonic cancers. Gan To Kagaku Ryoho, 2001, 28(11): 1505-1507.
  • 3Sugarbaker PH, Yu W, Yonemura Y, et al. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol, 2003, 21(4): 233-248.
  • 4Fujiwara Y, Taniguchi H, Kimura Y, et al. Two advanced gastric cancer patients who showed malignant ileus soon after administration of combination therapy of preoperative intra-peritoneal chemotherapy andgastrectomy. Gan To Kagaku Ryoho, 2003, 30(11): 161
  • 5Elias D, Bonnay M, Puizillou JM, et al. Heated intra-operative intraperitonealoxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol,2002, 13(2): 267-272.
  • 6Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. BrJ Surg, 2000, 87(2): 236-242.
  • 7Fushida S, Nao F, Kinami S, et al. Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination. Gan To Kagaku Ryoho, 2002, 29(10): 1759-1763.
  • 8Maruyama M, Nagahama T, Ebuchi M, et al. Experimental study on intraperitoneal versus intravenous CPT- 11 for peritoneal seeding andliver metastasis. Gan To Kagaku Ryoho, 2000, 27(12):1855-1857.
  • 9Maruyama M, Nagahama T, Yuasa Y, et al. Liver concentration of CPT-11, SN-38 and SN-38 GLU in intraperitoneal and intravenous administration of CPT-11. Gan To Kagaku Ryoho, 1999, 26(12): 1967-1969.
  • 10Markman M. Intraperitoneal chemotherapy. Crit Rev Oncol Hematol, 1999, 31(3): 239-246.

共引文献10

同被引文献14

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部